retatrutide type 2 diabetes trial dosing schedule dose schedule: complete week-by-week titration guide retatrutide clinical trials update trial

BenbrahimTallaa, L., Liu, J., Webber, M

These can include: Nausea, vomiting, or bloating Constipation, diarrhoea, or stomach discomfort Indigestion or heartburn Loss of appetite Feeling tired or weak Headache Redness, swelling, itching, or pain at the injection site Rarely, lumps or scarring may occur if injections are not rotated In rare cases, more serious risks can occur and may require immediate medical attention

While these medications are not primarily classified as hormonal therapies, their metabolic effects inevitably intersect with endocrine function, particularly in patients with obesity and insulin resistanceconditions known to disrupt multiple hormonal axes

Weigel, C., Kiener, C., Meier, N., Schmid, P., Rauh, M., Rascher, W., and Knerr, I

PMID: 37796527 63 PMDA FDA PubMed

Usually, the best results are achieved with 10 to 12 treatments spaced 6 to 8 weeks apart